Vol 6, Supplement 10 (December 2017): Translational Cancer Research (Focused Issue: Precision Dosing of Targeted Anticancer Drugs)

Disclosure:

The supplement “Precision Dosing of Targeted Anticancer Drugs” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding. Andrew Rowland and Michael J. Sorich served as the unpaid Guest Editors for the supplement.